(NEW YORK)Analysts say there may be more consolidation in the life sciences sector following Invitrogen Corp.'s purchase of Applied Biosystems Group and Thermo Fisher's acquisition o...READ MORE
(NEW YORK)Health care stocks ranging from drug developers to insurers mostly fell along with the broader market during the second quarter, according to Standard & Poor's, with Pfizer Inc...READ MORE
(NEW YORK)Shares of Illumina Inc. and Edwards Lifesciences hit new 52-week highs Wednesday, as a Cowen & Co. analyst said a potential increase in the National Institute of Health's fisca...READ MORE
(NEW YORK)Invitrogen Corp.'s recent $6.4 billion deal to buy Applied Biosystems Group has ramped up speculation about further consolidation in the life sciences sector, as companies vie ...READ MORE
(NEW YORK)Invitrogen Corp.'s planned $6.4 billion buyout of Applera's Applied Biosystems Group shone a spotlight on the wider life sciences product industry Thursday, boosting invest...READ MORE
(NEW YORK)Shares of Waters Corp. rose Wednesday morning as an analyst upgraded the analytical instrument maker, citing a recent drop in the stock's value following a fourth-quarter profit mi...READ MORE
(NEW YORK)Shares of Waters Corp. declined and helped tug the Standard & Poor's 500 index to a lower close on Tuesday, following broad market weakness caused by fears of an imminent recession...READ MORE